A randomized phase II study of Cisplatin plus S-1 versus Cisplatin plus Pemetrexed, with thoracic radiotherapy for locally advanced non-squamous non-small cell lung cancer
Phase 2
- Conditions
- on-squmous non-small cell lung cancer
- Registration Number
- JPRN-UMIN000009914
- Lead Sponsor
- ational Cancer Center Hospital East
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
(1) active concomitant malignancy (2) Infection, ileus, or gastrointestinal obstruction (3) Uncontrolled peptic ulcer or diabetes (4) Intestinal pneumonia or severe emphysema (5) Severe drug allergy (6) Concomitant use of other investigational drugs, warfarin, or flucytosine (7) Positive of HBsAg (8) Pregnancy or breast-feeding
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method